Steroids in prostate cancer: the jury is still out... and even more confused

Eur Urol. 2015 Apr;67(4):680-1. doi: 10.1016/j.eururo.2014.11.002. Epub 2014 Nov 20.

Authors

Camillo Porta¹, Sergio Bracarda², Romano Danesi³

Affiliations

¹ Medical Oncology, I.R.C.C.S. San Matteo University Hospital Foundation, Pavia, Italy. Electronic address: [email protected].
² Medical Oncology, Department of Oncology, San Donato Hospital, Tuscany Tumor Institute (ITT), Arezzo, Italy.
³ Clinical Pharmacology, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.

PMID: 25465980
DOI: 10.1016/j.eururo.2014.11.002

No abstract available

Publication types

Editorial
Comment

MeSH terms

Dexamethasone / therapeutic use*
Disease Progression*
Humans
Male
Prednisolone / therapeutic use*
Prostate-Specific Antigen / blood*
Prostatic Neoplasms, Castration-Resistant / drug therapy*

Substances

Dexamethasone
Prednisolone
Prostate-Specific Antigen